FI52089C - Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia. - Google Patents
Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia.Info
- Publication number
- FI52089C FI52089C FI129371A FI129371A FI52089C FI 52089 C FI52089 C FI 52089C FI 129371 A FI129371 A FI 129371A FI 129371 A FI129371 A FI 129371A FI 52089 C FI52089 C FI 52089C
- Authority
- FI
- Finland
- Prior art keywords
- benzo
- preparation
- therapeutically active
- naphthyridine derivatives
- active cis
- Prior art date
Links
- 150000005054 naphthyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH708670A CH527196A (de) | 1970-05-13 | 1970-05-13 | Verfahren zur Herstellung neuer Benzonaphthyridinderivate |
| CH708970A CH527822A (de) | 1970-05-13 | 1970-05-13 | Verfahren zur Herstellung neuer Benzonaphtyridin-Derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI52089B FI52089B (en:Method) | 1977-02-28 |
| FI52089C true FI52089C (fi) | 1977-06-10 |
Family
ID=25700728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI129371A FI52089C (fi) | 1970-05-13 | 1971-05-11 | Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia. |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5432799B1 (en:Method) |
| AT (1) | AT326674B (en:Method) |
| CA (1) | CA970377A (en:Method) |
| CS (2) | CS162753B2 (en:Method) |
| DE (1) | DE2123328A1 (en:Method) |
| DK (1) | DK134488B (en:Method) |
| ES (1) | ES391026A1 (en:Method) |
| FI (1) | FI52089C (en:Method) |
| FR (1) | FR2100649B1 (en:Method) |
| GB (1) | GB1361441A (en:Method) |
| NL (1) | NL7106502A (en:Method) |
| PL (1) | PL76913B1 (en:Method) |
| SE (1) | SE387640B (en:Method) |
| SU (1) | SU423296A3 (en:Method) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3899494A (en) * | 1970-05-13 | 1975-08-12 | Sandoz Ltd | Substituted 6-phenyl benzo-naphthyridines |
| NL7314396A (en:Method) * | 1972-10-26 | 1974-05-01 | ||
| BE880455A (fr) * | 1979-01-22 | 1980-06-06 | Sandoz Sa | Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine |
| US6384047B1 (en) | 1997-06-03 | 2002-05-07 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzonaphthyridine |
| KR100701904B1 (ko) | 1999-08-21 | 2007-04-02 | 알타나 파마 아게 | Ｐｄｅ 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합 |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| EA200501548A1 (ru) | 2003-04-01 | 2006-02-24 | Апплайд Резеч Системз Арс Холдинг Н.В. | Ингибиторы фосфодиэстераз при бесплодии |
| BRPI0510951A (pt) * | 2004-05-12 | 2007-11-20 | Pfizer Prod Inc | derivados de piperidina como antagonistas de nk1 e nk3 |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| AU2008261102B2 (en) | 2007-06-04 | 2013-11-28 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| AU2012223337C1 (en) | 2011-03-01 | 2016-11-10 | Bausch Health Ireland Limited | Process of preparing guanylate cyclase C agonists |
| US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| CN105764916B (zh) | 2013-06-05 | 2021-05-18 | 博士医疗爱尔兰有限公司 | 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法 |
| MX375926B (es) | 2013-08-09 | 2025-03-07 | Ardelyx Inc | Compuestos y metodos para inhibir el transporte de fosfato. |
| JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス， インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
-
1971
- 1971-05-10 GB GB1398471A patent/GB1361441A/en not_active Expired
- 1971-05-11 DE DE19712123328 patent/DE2123328A1/de not_active Ceased
- 1971-05-11 CS CS341671A patent/CS162753B2/cs unknown
- 1971-05-11 DK DK225771A patent/DK134488B/da unknown
- 1971-05-11 SU SU1656559A patent/SU423296A3/ru active
- 1971-05-11 PL PL14807271A patent/PL76913B1/pl unknown
- 1971-05-11 CS CS920771A patent/CS167202B2/cs unknown
- 1971-05-11 FI FI129371A patent/FI52089C/fi active
- 1971-05-11 ES ES391026A patent/ES391026A1/es not_active Expired
- 1971-05-12 FR FR7117124A patent/FR2100649B1/fr not_active Expired
- 1971-05-12 CA CA112,767A patent/CA970377A/en not_active Expired
- 1971-05-12 AT AT412471A patent/AT326674B/de not_active IP Right Cessation
- 1971-05-12 JP JP3189471A patent/JPS5432799B1/ja active Pending
- 1971-05-12 SE SE613471A patent/SE387640B/xx unknown
- 1971-05-12 NL NL7106502A patent/NL7106502A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL76913B1 (en) | 1975-02-28 |
| FR2100649A1 (en:Method) | 1972-03-24 |
| AT326674B (de) | 1975-12-29 |
| NL7106502A (en:Method) | 1971-11-16 |
| SU423296A3 (ru) | 1974-04-05 |
| FI52089B (en:Method) | 1977-02-28 |
| CA970377A (en) | 1975-07-01 |
| DK134488B (da) | 1976-11-15 |
| ES391026A1 (es) | 1974-04-01 |
| GB1361441A (en) | 1974-07-24 |
| DE2123328A1 (de) | 1971-12-02 |
| CS167202B2 (en:Method) | 1976-04-29 |
| JPS5432799B1 (en:Method) | 1979-10-16 |
| FR2100649B1 (en:Method) | 1974-08-30 |
| DK134488C (en:Method) | 1977-05-16 |
| ATA412471A (de) | 1975-03-15 |
| CS162753B2 (en:Method) | 1975-07-15 |
| SE387640B (sv) | 1976-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI52089C (fi) | Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia. | |
| NO140301C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(5,1-f)-as-triaziner | |
| SE400280B (sv) | 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner | |
| FI49300C (fi) | Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi. | |
| FI49515C (fi) | Menetelmä farmakologisesti vaikuttavien 11-asemaan substituoitujen 5,1 1-dihydro-6H-pyrido/2,3-b//1,4/bentsodiatsepiini-6-onien valmistamisek si. | |
| NO138565C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater | |
| FI49503C (fi) | Analogiamenetelmä 1,2,3,4-tetrahydro-4-fenyyli-isokinoliinijohdannaist en valmistamiseksi. | |
| FI48588C (fi) | Analogiamenetelmä terapeuttisesti vaikuttavien 3,4-dihydroisokinoliini johdannaisten valmistamiseksi. | |
| NO741744L (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av naftyridin. | |
| FI49827C (fi) | Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi. | |
| FI49504C (fi) | Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi. | |
| PH12247A (en) | Pharmaceutically active compounds | |
| NO740614L (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser. | |
| SE400768B (sv) | Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon | |
| NO741752L (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner. | |
| NO136574C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater. | |
| FI49718C (fi) | Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi. | |
| FI51349C (fi) | Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 6,7-bentsomor faanien valmistamiseksi. | |
| NO741044L (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive triaziner. | |
| FI49514C (fi) | Menetelmä farmaseuttisesti aktiivisten 11-asemaan substituoitujen 5,11 -dihydro-6H-pyrido(2,3-b)(1,4)bensodiatsepin-6-onien valmistamiseksi. | |
| FI50630C (fi) | Menetelmä farmakologisesti vaikuttavien 2,3,4,4a-tetrahydro-10H-1,2-ok satsino (3,2-b) (1,3) bentsoksatsiini-10-onien valmistamiseksi. | |
| FI50629C (fi) | Menetelmä uusien terapeuttisesti aktiivisten 2,3-dihydro-1H-tieno-bent sotiepino(4,5-c)pyrroli-yhdisteiden valmistamiseksi. | |
| FI47357C (fi) | Menetelmä terapeuttisesti vaikuttavien 4'-demetyyli-epipodofyllotoksii ni-beta-D-glukosidin johdannaisten valmistamiseksi. | |
| NO742973L (no) | Kjemisk mellomprodukt for bruk ved fremstilling av terapeutisk aktive 2,6-metan-3-benzazosiner. | |
| FI50875C (fi) | Menetelmä terapeuttisesti aktiivisten dihydro-2-aminoisokinoliinien va lmistamiseksi. |